期刊
CLINICAL CASE REPORTS
卷 7, 期 5, 页码 888-892出版社
WILEY
DOI: 10.1002/ccr3.2106
关键词
argatroban; dabigatran; hematology; hypercoagulability; lung adenocarcinoma; respiratory
资金
- Mitsubishi Tanabe Pharma
Key Clinical Message We report a case of lung adenocarcinoma-associated hypercoagulability leading to venous limb gangrene, managed successfully with argatroban and then dabigatran. Use of idarucizumab permitted diagnostic investigations, leading to targeted antineoplastic therapy with crizotinib, surgical resection with curative intent, and continued survival over 2 years after the index event.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据